« Previous
Next »
Titles
- BCG-unresponsive nonmuscle invasive bladder cancer: developing drugs and biologics for treatment1
- Bacterial risk control strategies for blood collection establishments and transfusion services to enhance the safety and availability of platelets for transfusion1
- Bacterial vaginosis: developing drugs for treatment1
- Behavioral health in rural America: challenges and opportunities1
- Behavioral health integration and workforce development1
- Behavioral health integration in Medi-Cal: a blueprint for California1
- Behavioral health integration: treating the whole person1
- Benefits and services1
- Best practices for communication between IND sponsors and FDA during drug development: guidance for industry and review staff : good review practice1
- Best practices for reducing unplanned acute care for patients with cancer1
- Beyond health care: the role of social determinants in promoting health and health equity1
- Billions in estimated Medicare Advantage payments from chart reviews raise concerns1
- Bioanalytical method validation1
- Biodefense: federal efforts to develop biological threat awareness : report to Congressional requesters1
- Biologic therapies for treatment of asthma associated with type 2 inflammation: effectiveness, value, and value-based price benchmarks : final evidence report1
- Brand name drug prices increase more than twice as fast as inflation in 20181
- Brand name prescription drug prices increase four times faster than inflation in 20171
- Breaking barriers for underrepresented minorities in the health professions1
- Breaking new ground: supporting employed family caregivers with workplace leave policies1
- Breaking through the noise: the facts about the Medicaid program1